Palmer, Adam C.
University of North Carolina at Chapel Hill
3 papers on CoChatORCID 0000-0001-5028-7028
Most cited papers
- Verified
Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy
Palmer, A. C., & Sorger, P. K. (2017) · Cell
Cancer Cells and MetastasisMathematical Biology Tumor Growth
Cited by 642
- Verified
Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors
Goel, S., Wang, Q., Watt, A. C., Tolaney, S. M., Dillon, D. A., Li, W., Ramm, S., Palmer, A. C., Yuzugullu, H., Varadan, V., et al. (2016) · Cancer Cell
Advanced Breast Cancer TherapiesPI3K/AKT/mTOR signaling in cancer
Cited by 470
- Verified
DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas
He, Y., Koch, R., Budamagunta, V., Zhang, P., Zhang, X., Khan, S., Thummuri, D., Ortiz, Y. T., Zhang, X., Lv, D., et al. (2020) · Journal of Hematology & Oncology
Protein Degradation and InhibitorsCell death mechanisms and regulation
Cited by 139
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free